Search results
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
Morningstar· 3 days agoFood and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment
Prudent Picks for Value, Growth and Yield
MoneyShow via Yahoo Finance· 1 week agoValue stocks, per data from June 1927 through January 2024, have topped the long-term performance scorecard versus growth by a score of 13.2% to 9.6% per annum, reports John Buckingham, editor of The Prudent Speculator.
